Alerje founder Javier Evelyn’s mobile auto-injector platform was recently acquired by SemPresto.
NS002 demonstrated significantly faster time to the critical 100 pg/mL epinephrine threshold compared to EpiPen®, with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results